Sponsor

Dartmouth-Hitchcock Medical Center

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Dartmouth-Hitchcock Medical Center appears in 170 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials170
Recruiting shown12
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer SurvivorsNCT07706556 · lead sponsor · 2026-06-30
RECRUITING
Remote Evaluation and Alerting for Collaborative Health (REACH) in DepressionNCT07174557 · lead sponsor · 2026-05-20
RECRUITING
Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer PatientsNCT07071038 · lead sponsor · 2025-10-17
RECRUITING
HOBSCOTCH-MS-Efficacy TrialNCT06951919 · lead sponsor · 2025-09-09
RECRUITING
Testing a Mammography Decision Intervention in a Rural SettingNCT06522568 · lead sponsor · 2025-09-01
RECRUITING
A Study of Tetrathiomolybdate (TM) Plus CapecitabineNCT06134375 · lead sponsor · 2024-11-26
RECRUITING
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 InhibitorNCT05933395 · lead sponsor · 2024-09-23
RECRUITING
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulationNCT06258993 · lead sponsor · 2024-04-16
RECRUITING
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older AdultsNCT05955339 · lead sponsor · 2024-01-24
RECRUITING
Healthy Homes StudyNCT05833334 · lead sponsor · 2023-06-01
RECRUITING
STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)NCT05716516 · lead sponsor · 2023-05-04
RECRUITING
Low-Dose Naltrexone for the Treatment of Painful Diabetic NeuropathyNCT04678895 · lead sponsor · 2020-12-22
RECRUITING
iPath for CP PilotNCT07631247 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
aPBI Re-irradiationNCT07612254 · lead sponsor · 2026-06-03
NOT_YET_RECRUITING
Pilot Trial of the Move Healthier GroupNCT07406568 · lead sponsor · 2026-04-16
COMPLETED
24GUT540 : Meeting of Breast Cancer Patients and PathologistsNCT07040514 · lead sponsor · 2025-07-10
COMPLETED
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's)NCT06260228 · lead sponsor · 2024-01-05
ACTIVE_NOT_RECRUITING
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS)NCT06145737 · lead sponsor · 2024-01-02
ACTIVE_NOT_RECRUITING
The Effect of Clinic Visit Audio Recordings for Self-management in Older AdultsNCT05824572 · lead sponsor · 2023-12-01
ACTIVE_NOT_RECRUITING
An Observational Pilot Study to Test a Smartwatch-based EMA Method During Exercise With Breast Cancer SurvivorsNCT05868746 · lead sponsor · 2023-06-16
COMPLETED
The Science of the Art of Palliative CareNCT05137782 · lead sponsor · 2023-01-03
COMPLETED
High-fat Meal Challenge in PediatricsNCT05230433 · lead sponsor · 2022-05-01
COMPLETED
Relationship Between the Development of Impaired Glucose Tolerance, the Phenotype of CFLD, and the Risk of Liver FibrosisNCT05229640 · lead sponsor · 2022-03-31
WITHDRAWN
21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI TrialNCT05131607 · lead sponsor · 2022-03-17
UNKNOWN
Acupuncture to Enhance for Pulmonary RehabNCT04947800 · lead sponsor · 2022-01-25
TERMINATED
A Culinary-Based Intensive Lifestyle Program for Patients With ObesityNCT04624620 · lead sponsor · 2022-01-11
COMPLETED
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)NCT04568616 · lead sponsor · 2021-08-13
ACTIVE_NOT_RECRUITING
A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulationNCT04903249 · lead sponsor · 2021-08-10
COMPLETED
Understanding Rural Patient and Provide Preferences for Mobile Lung Cancer Screening ClinicsNCT04926662 · lead sponsor · 2021-07-14
SUSPENDED
Peer-delivered and Technology-Assisted Integrated Illness Management and RecoveryNCT04481737 · lead sponsor · 2021-02-01
COMPLETED
EHR Embedded Comparative Effectiveness Studies--WWCNCT04514679 · lead sponsor · 2020-10-23
COMPLETED
A Mind-Body Intervention for Diabetes Management: A Pilot StudyNCT04944264 · lead sponsor · 2020-10-01
COMPLETED
The Impact of Sharing Audio Recorded Clinic Visits on Self-management in Older AdultsNCT04344301 · lead sponsor · 2020-08-31
COMPLETED
Artificial Intelligence for Prostate Cancer Treatment PlanningNCT04441775 · lead sponsor · 2020-06-22
COMPLETED
Lumpectomy Specimen Margin Evaluation With Tomography and Structured Light ImagingNCT04257799 · lead sponsor · 2020-02-06
COMPLETED
Evaluating Right Ventricular (RV) Size and Function Using the Upper Valley RV Algorithm and Novel Imaging ModalitiesNCT03935178 · lead sponsor · 2019-08-05
TERMINATED
Evaluation of the Healthy Lifestyle Program on Cognitive OutcomesNCT03926481 · lead sponsor · 2019-07-10
TERMINATED
LoveYourBrain Yoga for Multiple SclerosisNCT03827928 · lead sponsor · 2019-07-01
COMPLETED
Trial on the Effect of Media Multi-tasking on Attention to Food Cues and Cued OvereatingNCT03882957 · lead sponsor · 2019-06-05
COMPLETED
Neurology Inpatient Clinical Education TrialNCT03826056 · lead sponsor · 2019-02-01
COMPLETED
MOWI Home-Based PilotNCT03104205 · lead sponsor · 2018-10-01
COMPLETED
Foundations of Fitness Program PilotNCT03622086 · lead sponsor · 2018-07-12
COMPLETED
The Prone to Supine Breast MRI TrialNCT03573804 · lead sponsor · 2018-07-12
COMPLETED
A Remotely Supervised Exercise Program for Lung Cancer Patients Undergoing Chemoradiation (REM)NCT03500393 · lead sponsor · 2018-06-22
TERMINATED
A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable CancersNCT03573661 · lead sponsor · 2018-05-24
COMPLETED
Health Coaching & Technology in a Weight Loss CenterNCT03309787 · lead sponsor · 2017-11-29
COMPLETED
What Matters Most: Choosing the Right Breast Cancer Surgery for YouNCT03136367 · lead sponsor · 2017-09-18
COMPLETED
A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer SurgeryNCT03162718 · lead sponsor · 2017-09-14
COMPLETED
MOWI Research PilotNCT03104192 · lead sponsor · 2017-09-01
COMPLETED
Lifestyle Intervention for Young Adults With Serious Mental IllnessNCT02815813 · lead sponsor · 2017-07-03
COMPLETED
The Multiple Sclerosis Continuous Quality Improvement (MSCQI) CollaborativeNCT03480854 · lead sponsor · 2017-07-01
COMPLETED
The Appeal and Impact of E-cigarettes in Smokers With SMINCT03050853 · lead sponsor · 2017-03-01
COMPLETED
Estrogen Receptor-Positive Breast Cancer Patient-Derived XenograftsNCT02752893 · lead sponsor · 2017-01-30
COMPLETED
MOWI Amulet Mobile Health Technology ValidationNCT03085589 · lead sponsor · 2016-08-16
COMPLETED
MOWI Qualitative AssessmentNCT03041831 · lead sponsor · 2016-08-15
COMPLETED
The Impact of Three Distinct Exercise Types on Fatigue, Anxiety, and Depression in Parkinson's DiseaseNCT02885285 · lead sponsor · 2016-08-01
TERMINATED
Evaluation of Appeal and Impact of E-Cigarettes Among Chronic Smokers With Smoking-Related CancersNCT02648178 · lead sponsor · 2016-06-01
COMPLETED
ER Reactivation Therapy for Breast CancerNCT02188745 · lead sponsor · 2016-03-11
COMPLETED
Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort StudyNCT02575898 · lead sponsor · 2016-01-14
COMPLETED
Development of a Mobile System for Self-management of Schizophrenia (SOS)NCT01969500 · lead sponsor · 2015-11-01
COMPLETED

Drugs studied in this sponsor's trials

41 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Dartmouth-Hitchcock Medical Center as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo8
clozapine6
aprepitant2
capecitabine2
docetaxel2
dronabinol2
fulvestrant2
letrozole2
placebo RxCUI 8375 · Lead sponsor in 6 linked trial(s) · 1 currently recruiting 8 trials clozapine RxCUI 2626 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 6 trials aprepitant RxCUI 358255 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials capecitabine RxCUI 194000 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials docetaxel RxCUI 72962 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials dronabinol RxCUI 10402 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials fulvestrant RxCUI 282357 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 2 trials letrozole RxCUI 72965 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials risperidone RxCUI 35636 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials abatacept RxCUI 614391 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial abemaciclib RxCUI 1946825 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial Acthar RxCUI 1040019 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial alpelisib RxCUI 2169285 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial anastrozole RxCUI 84857 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial aprotinin RxCUI 1056 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial arformoterol RxCUI 304962 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial arformoterol tartrate RxCUI 668284 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial chlorpromazine RxCUI 2403 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial Copaxone RxCUI 135779 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial estradiol RxCUI 4083 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial estriol RxCUI 4094 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial everolimus RxCUI 141704 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial exemestane RxCUI 258494 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial gefitinib RxCUI 328134 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor146
collaborator24
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.